 |
 |
|
|
RESÚMENES OCTUBRE 2005 |
Addictive Disorders
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Methylphenidate
increases cigarette smoking
Rush CR, Higgins ST,
Vansickel AR, Stoops WW, Lile JA, Glaser PE
Psychopharmacology (Berl). 2005 Oct;181(4):781-9. Epub
2005 Sep 29
BOBBY P. SMYTH, JOE BARRY, ALISON LANE, MARY COTTER, MARY O’NEILL,
CAROLINE QUINN, and EAMON KEENAN
The British Journal of Psychiatry (2005) 187: 360-365
Buprenorphine/naloxone
reduces the reinforcing and subjective effects of heroin in heroin-dependent
volunteers
Comer SD, Walker EA,
Collins ED
Psychopharmacology (Berl).
2005 Oct;181(4):664-75. Epub 2005 Sep 29
Increasing treatment options for cannabis dependence: A review of potential pharmacotherapies
Carl L. Hart
Drug and Alcohol Dependence. Volume 80, Issue 2, 1
November 2005, Pages 147-159
Desipramine treatment of cocaine-dependent patients with depression: A placebo-controlled trial
David McDowell,
Edward V. Nunes, Angela M. Seracini, Jami Rothenberg, Suzanne K. Vosburg,
Guoguang J. Ma and Eva Petkova
Drug and Alcohol Dependence. Volume 80, Issue 2, 1
November 2005, Pages 209-221
Nucleus accumbens dopamine release is necessary and sufficient to promote the behavioral response to reward-predictive cues
S.M. Nicola, S.A.
Taha, S.W. Kim and H.L. Fields
Neuroscience. Volume 135, Issue 4, 2005, Pages
1025-1033
Harold B.
Pinkofsky, Ann M. Hahn, Frances A. Campbell, John Rueda, Dennis C. Daley, and
Antoine B. Douaihy
J Clin Psychiatry 2005;66:1285-1288
Reductions in and relations between “craving” and drinking in a prospective, open-label trial of ondansetron in adolescents with alcohol dependence
Michael A. Dawes,
Bankole A. Johnson, Jennie Z. Ma, Nassima Ait-Daoud, Suzanne E. Thomas and Jack
R. Cornelius
Addictive Behaviors. Volume 30, Issue 9, October 2005,
Pages 1630-1637
What came first, major depression or substance use disorder? Clinical characteristics and substance use comparing teens in a treatment cohort
Anne M. Libby,
Heather D. Orton, Shannon K. Stover and Paula D. Riggs
Addictive Behaviors. Volume 30, Issue 9, October 2005,
Pages 1649-1662
Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: Results from a double blind, placebo-controlled study
Ihsan M. Salloum,
Jack R. Cornelius, Antoine Douaihy, Levant Kirisci, Dennis C. Daley and Thomas
M. Kelly
Addictive Behaviors. Volume 30, Issue 9, October 2005,
Pages 1702-1708
Dawn L. Thatcher,
Jack R. Cornelius and Duncan B. Clark
Addictive
Behaviors. Volume 30, Issue 9, October 2005, Pages 1709-1724
Cannabinoid Agonists but not Inhibitors of Endogenous
Cannabinoid Transport or Metabolism Enhance the Reinforcing Efficacy of Heroin
in Rats
Marcello Solinas, Leigh V Panlilio,
Gianluigi Tanda, Alexandros Makriyannis, Stephanie A Matthews and Steven R
Goldberg
Neuropsychopharmacology (2005) 30, 2046-2057
Ionotropic Glutamate Receptors in the Ventral Tegmental Area
Regulate Cocaine-Seeking Behavior in Rats
WenLin Sun, Chana K Akins, Anne E
Mattingly and George V Rebec
Neuropsychopharmacology (2005) 30, 2073-2081
Aripiprazole Attenuates the Discriminative-Stimulus and
Subject-Rated Effects of D-Amphetamine
in Humans
Joshua A Lile, William W Stoops,
Andrea R Vansickel, Paul E A Glaser, Lon R Hays and Craig R Rush
Neuropsychopharmacology (2005) 30, 2103-2114
An open randomized
study comparing disulfiram and acamprosate in the treatment of alcohol
dependence
DE Sousa A
Alcohol Alcohol. 2005
Nov-Dec;40(6):545-8. Epub 2005 Jul 25
Persistence
of antidepressant treatment effects in a pharmacotherapy plus psychotherapy
trial for active injection drug users
Stein MD, Solomon DA, Anderson
BJ, Herman DS, Anthony JL, Brown RA, Ramsey SE, Miller IW
Am J Addict. 2005 Jul-Sep;14(4):346-57
Robert F.
Ferdinand, Jan van der Ende, Ilja Bongers, Jean-Paul Selten, Anja Huizink and
Frank C. Verhulst
Schizophrenia
Research. Volume 79, Issues 2-3, 15 November 2005, Pages 289-295
Efficacy
of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for
or With Chronic Obstructive Pulmonary Disease
E.
J. Wagena, P. G. Knipschild, M. J. H. Huibers, E. F. M. Wouters, C. P. van
Schayck
Arch Intern Med. 2005;165:2286-2292
A
randomized, open-label pilot comparison of gabapentin and bupropion SR for
smoking cessation
White WD, Crockford D,
Patten S, El-Guebaly N
Nicotine Tob Res. 2005 Oct;7(5):809-13
Effect
of sustained-release (SR) bupropion on craving and withdrawal in smokers
deprived of cigarettes for 72 h
Teneggi V, Tiffany ST,
Squassante L, Milleri S, Ziviani L, Bye A
Psychopharmacology (Berl). 2005 Nov;183(1):1-12. Epub
2005 Oct 22
Gwenolé Loas,
Olivier Guilbaud, Fernando Perez-Diaz, Annie Verrier, Philippe Stephan,
François Lang, Paul Bizouard, Jean Luc Venisse, Maurice Corcos, Martine F.
Flament, Philippe Jeammet and the Réseau INSERM no. 494013
Psychiatry Research. Volume 137, Issues 1-2, 15 November 2005,
Pages 103-111